Skip to main content
. 2021 Oct 12;11:20197. doi: 10.1038/s41598-021-99756-1

Figure 3.

Figure 3

(A) Concentration-dependent reduction of cell viability by nobiletin solution and nobiletin vesicular systems after 24 h, calculated for human epidermoid carcinoma A431 cell line using the MTT assay (n = 3), (B) Concentration-dependent reduction of cell viability by nobiletin solution and nobiletin vesicular systems after 48 h, calculated for human epidermoid carcinoma A431 cell line using the MTT assay (n = 3).